BioWa seeks new antibody opportunity in backing new startup Caerus
This article was originally published in Scrip
Executive Summary
Antibody developer BioWa is betting that the "gods" of opportunity, luck and favorable moments are smiling on its new venture in backing Virginia-based biotech startup Caerus Discovery, which was founded on decade-old technology, whose discoverer insists its time has come.